Sorrento Therapeutics, Inc.

Delisted

CIK 850261fmd_1K2S4Q2ABT1BTXA8ZW5E3A4SMFManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2007 to Jun 30, 2023, 56 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).